Following adults newly diagnosed with type 1 or type 2 diabetes over time
Studies how diabetes changes over time in adults aged 18 to 69 newly diagnosed.
Plain-language title generated from the registry record
Registry title: Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients
Key facts
- Where
- Düsseldorf, GermanySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 69 years old?
Source: NCT01055093, who can take part
Where in Germany
- German Diabetes CenterDüsseldorf, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- German Diabetes Center
- Trial code
- NCT01055093
- Record updated
- 16 July 2025
- Original description
The aim of the prospective observational GDC-Study in patients with newly diagnosed diabetes mellitus aged 18-69 years at inclusion into the study is to characterize in detail the clinical, metabolical and immunological phenotype and monitor the progression of the disease and to compare the phenotype to glucose tolerant humans of similar age, body mass and sex distribution.Read full original descriptionShow less
Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients
The aim of the prospective observational GDC-Study in patients with newly diagnosed diabetes mellitus aged 18-69 years at inclusion into the study is to characterize in detail the clinical, metabolical and immunological phenotype and monitor the progression of the disease and to compare the phenotype to glucose tolerant humans of similar age, body mass and sex distribution.
Inclusion: Clinical diagnosis of diabetes mellitus according to ADA criteria; Age 18-69; Diabetes duration since diagnosis < 12 months; Control cohort: proven normal glucose tolerance according to ADA criteria.
Exclusion: Diabetes mellitus category 3 B-H (ADA criteria); Severe renal, liver or heart disease; malignant cancer; severe psychiatric illness or addiction; Pregnancy; participation in an intervention trial.